FATE : Fate Therapeutics stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-06-06 |
|---|---|---|---|---|
| 2023 | $6.65 | $5.8 | $7.11 | 20.51% |
| 2024 | $4.77 | $2.89 | $6.6 | -13.56% |
| 2025 | $2.34 | $1.66 | $2.83 | -57.68% |
| 2026 | $1.33 | $1.19 | $1.56 | -75.95% |
| 2027 | $1.4 | $1.12 | $2.22 | -74.63% |
| 2028 | $4.13 | $2.49 | $6.28 | -25.24% |
| 2029 | $12.15 | $6.91 | $17.72 | 120.17% |
| 2030 | $23.04 | $18.69 | $26.37 | 317.33% |
| 2031 | $29.97 | $26.71 | $31.48 | 443.0% |
| 2032 | $34.11 | $31.92 | $36.07 | 517.99% |
| 2033 | $37.7 | $36.51 | $38.66 | 582.93% |
The 34 Wall Street analysts offering Fate Therapeutics stock forecast in the last 6 months have average price target of
$13.61 with a high forecast of $62.0 and a low forecast of $4.0.
The average Fate Therapeutics stock forecast represents a 146.56%
increase from the last price of $5.51999998092651.
From AI system, total return is 2366.52% from 4098 forecasts.
For Fate Therapeutics stock forecast for 2023, 6 predictions are offered for each month of 2023 with average Fate Therapeutics stock
forecast of $6.65, a high forecast of $7.11, and a low forecast of $5.8.
The average Fate Therapeutics stock forecast 2023 represents a 20.51%
increase from the last price of $5.51999998092651.
For Fate Therapeutics stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Fate Therapeutics stock
forecast of $4.77, a high forecast of $6.6, and a low forecast of $2.89.
The average Fate Therapeutics stock forecast 2024 represents a -13.56%
decrease from the last price of $5.51999998092651.
For Fate Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Fate Therapeutics stock
forecast of $1.33, a high forecast of $1.56, and a low forecast of $1.19.
The average Fate Therapeutics stock forecast 2026 represents a -75.95%
decrease from the last price of $5.51999998092651.
For Fate Therapeutics stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Fate Therapeutics stock
forecast of $4.13, a high forecast of $6.28, and a low forecast of $2.49.
The average Fate Therapeutics stock forecast 2028 represents a -25.24%
decrease from the last price of $5.51999998092651.
For Fate Therapeutics stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Fate Therapeutics stock
forecast of $29.97, a high forecast of $31.48, and a low forecast of $26.71.
The average Fate Therapeutics stock forecast 2031 represents a 443.0%
increase from the last price of $5.51999998092651.
For Fate Therapeutics stock forecast for 2033 (10 year), 6 predictions are offered for each month of 2033 with average Fate Therapeutics stock
forecast of $37.7, a high forecast of $38.66, and a low forecast of $36.51.
The average Fate Therapeutics stock forecast 2033 represents a 582.93%
increase from the last price of $5.51999998092651.
Please, see more forecasts below.
FATE : Fate Therapeutics stock forecast by Wall Street Analysts
The average Fate Therapeutics stock forecast from last 6 month is $13.61, and this show a -69.76% decrease in average from the prior price target of the each prediction. Also, this average forecast of $13.61 represents a -74.86% decrease from the past average forecast of $54.14, 6 months ago from 7 wall street analysts.
Fate Therapeutics stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-06-08 | $5.41 | -2.02% |
| 2023-06-09 | $5.36 | -0.82% |
| 2023-06-12 | $5.68 | 5.96% |
| 2023-06-13 | $5.85 | 2.94% |
| 2023-06-14 | $5.80 | -0.89% |
FATE : Long term Fate Therapeutics stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Jul. is $5.80 , for 2024 Jun. is $4.91 , for 2027 Jun. is $1.17 , for 2028 Jun. is $3.76 , for 2032 Jun. is $34.02 , and for 2033 Jun. is $38.45.
FATE : Fate Therapeutics stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jul. | $5.80 | 5.16% |
| 2023 Aug. | $6.27 | 7.95% |
| 2023 Sep. | $6.74 | 7.57% |
| 2023 Oct. | $7.05 | 4.59% |
| 2023 Nov. | $7.11 | 0.81% |
| 2023 Dec. | $6.94 | -2.30% |
FATE : Fate Therapeutics stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $6.60 | -5.00% |
| 2024 Feb. | $6.29 | -4.69% |
| 2024 Mar. | $6.39 | 1.59% |
| 2024 Apr. | $6.10 | -4.51% |
| 2024 May. | $5.45 | -10.73% |
| 2024 Jun. | $4.91 | -9.80% |
| 2024 Jul. | $4.52 | -7.90% |
| 2024 Aug. | $4.13 | -8.82% |
| 2024 Sep. | $3.69 | -10.59% |
| 2024 Oct. | $3.30 | -10.66% |
| 2024 Nov. | $3.00 | -8.96% |
| 2024 Dec. | $2.89 | -3.61% |
FATE : Fate Therapeutics stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $2.83 | -2.21% |
| 2025 Feb. | $2.78 | -1.81% |
| 2025 Mar. | $2.71 | -2.49% |
| 2025 Apr. | $2.61 | -3.45% |
| 2025 May. | $2.51 | -3.94% |
| 2025 Jun. | $2.51 | -0.01% |
| 2025 Jul. | $2.47 | -1.62% |
| 2025 Aug. | $2.23 | -9.55% |
| 2025 Sep. | $2.04 | -8.78% |
| 2025 Oct. | $1.90 | -6.88% |
| 2025 Nov. | $1.78 | -6.09% |
| 2025 Dec. | $1.66 | -6.64% |
FATE : Fate Therapeutics stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $1.56 | -6.20% |
| 2026 Feb. | $1.46 | -6.25% |
| 2026 Mar. | $1.40 | -4.60% |
| 2026 Apr. | $1.35 | -3.05% |
| 2026 May. | $1.33 | -1.90% |
| 2026 Jun. | $1.31 | -1.23% |
| 2026 Jul. | $1.30 | -0.87% |
| 2026 Aug. | $1.29 | -0.77% |
| 2026 Sep. | $1.27 | -1.17% |
| 2026 Oct. | $1.25 | -1.87% |
| 2026 Nov. | $1.22 | -2.52% |
| 2026 Dec. | $1.19 | -2.78% |
FATE : Fate Therapeutics stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $1.15 | -2.73% |
| 2027 Feb. | $1.13 | -2.09% |
| 2027 Mar. | $1.12 | -1.19% |
| 2027 Apr. | $1.12 | 0.06% |
| 2027 May. | $1.13 | 1.56% |
| 2027 Jun. | $1.17 | 3.50% |
| 2027 Jul. | $1.24 | 5.97% |
| 2027 Aug. | $1.35 | 8.77% |
| 2027 Sep. | $1.51 | 11.45% |
| 2027 Oct. | $1.71 | 13.44% |
| 2027 Nov. | $1.95 | 14.23% |
| 2027 Dec. | $2.22 | 13.70% |
FATE : Fate Therapeutics stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $2.49 | 12.27% |
| 2028 Feb. | $2.75 | 10.41% |
| 2028 Mar. | $2.99 | 8.63% |
| 2028 Apr. | $3.22 | 7.60% |
| 2028 May. | $3.47 | 7.69% |
| 2028 Jun. | $3.76 | 8.52% |
| 2028 Jul. | $4.11 | 9.29% |
| 2028 Aug. | $4.50 | 9.43% |
| 2028 Sep. | $4.90 | 8.89% |
| 2028 Oct. | $5.31 | 8.36% |
| 2028 Nov. | $5.75 | 8.41% |
| 2028 Dec. | $6.28 | 9.11% |
FATE : Fate Therapeutics stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $6.91 | 10.14% |
| 2029 Feb. | $7.68 | 11.01% |
| 2029 Mar. | $8.55 | 11.35% |
| 2029 Apr. | $9.50 | 11.19% |
| 2029 May. | $10.52 | 10.66% |
| 2029 Jun. | $11.56 | 9.94% |
| 2029 Jul. | $12.62 | 9.13% |
| 2029 Aug. | $13.66 | 8.30% |
| 2029 Sep. | $14.69 | 7.54% |
| 2029 Oct. | $15.71 | 6.93% |
| 2029 Nov. | $16.72 | 6.42% |
| 2029 Dec. | $17.72 | 5.96% |
FATE : Fate Therapeutics stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $18.69 | 5.46% |
| 2030 Feb. | $19.61 | 4.95% |
| 2030 Mar. | $20.50 | 4.51% |
| 2030 Apr. | $21.34 | 4.15% |
| 2030 May. | $22.18 | 3.89% |
| 2030 Jun. | $22.98 | 3.64% |
| 2030 Jul. | $23.74 | 3.31% |
| 2030 Aug. | $24.44 | 2.91% |
| 2030 Sep. | $25.04 | 2.48% |
| 2030 Oct. | $25.56 | 2.07% |
| 2030 Nov. | $26.00 | 1.71% |
| 2030 Dec. | $26.37 | 1.44% |
FATE : Fate Therapeutics stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $26.71 | 1.30% |
| 2031 Feb. | $27.12 | 1.50% |
| 2031 Mar. | $28.17 | 3.89% |
| 2031 Apr. | $30.37 | 7.82% |
| 2031 May. | $31.15 | 2.57% |
| 2031 Jun. | $30.84 | -1.01% |
| 2031 Jul. | $30.84 | 0.01% |
| 2031 Aug. | $30.43 | -1.33% |
| 2031 Sep. | $30.58 | 0.51% |
| 2031 Oct. | $30.85 | 0.88% |
| 2031 Nov. | $31.13 | 0.90% |
| 2031 Dec. | $31.48 | 1.13% |
FATE : Fate Therapeutics stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $31.92 | 1.40% |
| 2032 Feb. | $32.41 | 1.52% |
| 2032 Mar. | $32.88 | 1.46% |
| 2032 Apr. | $33.30 | 1.29% |
| 2032 May. | $33.67 | 1.12% |
| 2032 Jun. | $34.02 | 1.03% |
| 2032 Jul. | $34.36 | 1.01% |
| 2032 Aug. | $34.71 | 1.01% |
| 2032 Sep. | $35.03 | 0.94% |
| 2032 Oct. | $35.33 | 0.83% |
| 2032 Nov. | $35.66 | 0.93% |
| 2032 Dec. | $36.07 | 1.16% |
FATE : Fate Therapeutics stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $36.51 | 1.23% |
| 2033 Feb. | $36.96 | 1.22% |
| 2033 Mar. | $37.47 | 1.37% |
| 2033 Apr. | $38.14 | 1.80% |
| 2033 May. | $38.66 | 1.36% |
| 2033 Jun. | $38.45 | -0.55% |
Frequently Asked Questions about Fate Therapeutics stock forecast
Is Fate Therapeutics a good long term stock?
From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock can be a good investment choice. According to Tudal, the Fate Therapeutics stock price forecast for 2023 Jul. is $5.80473419262725 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock cannot be a good investment choice. According to Tudal, the Fate Therapeutics stock price forecast for 2024 Jun. is $4.91208698706775 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock cannot be a good investment choice. According to Tudal, the Fate Therapeutics stock price forecast for 2027 Jun. is $1.17326113784312 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock cannot be a good investment choice. According to Tudal, the Fate Therapeutics stock price forecast for 2028 Jun. is $3.76033244075343 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock can be a good investment choice. According to Tudal, the Fate Therapeutics stock price forecast for 2032 Jun. is $34.0184620212362 From Fate Therapeutics stock forecast , Fate Therapeutics (FATE) stock can be a good investment choice. According to Tudal, the Fate Therapeutics stock price forecast for 2033 Jun. is $38.44842514804
Is Fate Therapeutics stock overvalued?
Fate Therapeutics (FATE) stock is expected to go DOWN . Therefore, Tudal would say that Fate Therapeutics (FATE) stock is overvalued.
Will Fate Therapeutics stock price go up?
No. The Fate Therapeutics stock price forecast for 2024 Jun. is $4.91208698706775
Is Fate Therapeutics stock a good buy now?
Since closing price on 2023-06-06 is $5.51999998092651 and forecast for 2024 Jun. is $4.91, Fate Therapeutics stock is not a good 1 year investment.